Upregulation of APAF1 and CSF1R in Peripheral Blood Mononuclear Cells of Parkinson's Disease.

Increased oxidative stress and neuroinflammation play a crucial role in the pathogenesis of Parkinson's disease (PD). In this study, the expression levels of 52 genes related to oxidative stress and inflammation were measured in peripheral blood mononuclear cells of the discovery cohort including 48 PD patients and 25 healthy controls. Four genes, including , , , and , were found to be upregulated in PD patients. The expression patterns of these genes were validated in a second cohort of 101 PD patients and 61 healthy controls. The results confirmed the upregulation of (PD: 0.34 ± 0.18, control: 0.26 ± 0.11, < 0.001) and (PD: 0.38 ± 0.12, control: 0.33 ± 0.10, = 0.005) in PD patients. The expression level of was correlated with the scores of the Unified Parkinson's Disease Rating Scale (UPDRS, r = 0.235, = 0.018) and 39-item PD questionnaire (PDQ-39, r = 0.250, = 0.012). The expression level of was negatively correlated with the scores of the mini-mental status examination (MMSE, r = -0.200, = 0.047) and Montréal Cognitive Assessment (MoCA, r = -0.226, = 0.023). These results highly suggest that oxidative stress biomarkers in peripheral blood may be useful in monitoring the progression of motor disabilities and cognitive decline in PD patients.